Membrane Sodium Potassium Atpase Inhibition Mediated Atp Synthesis Induced by Digoxin, Photoinduction and Electromagnetic Fields
Methodology: The following groups were included in the study: -endomyocardial fibrosis, alzheimer’s disease, multiple sclerosis, non-hodgkin’s lymphoma, metabolic syndrome x with cerebrovascular thrombosis and coronary artery disease, schizophrenia, autism, seizure disorder, creutzfeldt jakob disease and acquired immunodeficiency syndrome. There were 10 patients in each group and each patient had an age and sex matched healthy control selected randomly from the general population. The blood samples were drawn in the fasting state before treatment was initiated. Membrane sodium potassium ATPase was inhibited by the addition of digoxin at concentration 1 mg/ml and exposure to sunlight and low intensity electromagnetic fields for 1 hour. The ATP synthesis by membrane sodium potassium ATPase in the inhibited state was studied.
Results: The results of the study showed increased ATP synthesis by RBC membrane sodium potassium ATPase in the presence of added digoxin, exposure to sunlight and low intensity electromagnetic fields. The added digoxin, exposure to sunlight and low intensity electromagnetic fields produce sodium potassium ATPase inhibition. Membrane sodium potassium ATPase in its inhibited state can synthesize ATP. The results are expressed as percentage change in the parameters after 1 hour incubation as compared to the values at zero time. There was RBC membrane sodium potassium ATPase mediated ATP synthesis in the patients with schizophrenia, malignancy, metabolic syndrome x, autoimmune disease and neuronal degeneration in the presence of added digoxin, exposure to sunlight and low intensity electromagnetic fields.
Conclusion: The membrane sodium potassium ATPase inhibition mediated ATP synthesis may serve as a major source of cellular energetics. The sunlight induced photic induction of membrane sodium potassium ATPase inhibition may be a primitive source of cellular energy before the evolution of mitochondrial oxidative phosphorylation. The electromagnetic induction of membrane sodium potassium ATPase inhibition mediated ATP synthesis may also be a similar primitive source of cellular energy. The photic and electromagnetic inhibition mediated membrane sodium potassium ATPase inhibition related ATP synthesis still serves as a major source of cellular energetics despite the presence of mitochondrial oxidative phosphorylation and anaerobic glycolysis.
Key words: Membrane sodium potassium ATPase; Digoxin; Photic induction; Electromagnetic fields; ATP synthesis
Kurup R. & Kurup, P. A. (2009). Hypothalamic Digoxin, Cerebral Dominance and Brain Function in Health and Diseases. New York: Nova Science Publishers.
Snell E. D. & Snell, C.T. (1961). Colorimetric Methods of Analysis. Vol. 3A. New York: Van NoStrand.
Glick, D. (1971). Methods of Biochemical Analysis. Vol. 5. New York: Interscience Publishers.
Colowick, Kaplan, N. O. (1955). Methods in Enzymology. Vol. 2. New York: Academic Press.
Skaper S. D., Debetto P. & Giusti P. (2010). The P2X7 Purinergic Receptor: From Physiology to Neurological Disorders. FASEB J., 24(2), 337-45.
Burnstock, G. (2008). Purinergic Signalling and Disorders of the Central Nervous System. Nature Reviews Drug Discovery, 7, 575-590.
White, N., Burnstock, G. (2006). P2 Receptors and Cancer. Trends in Pharmacological Sciences, 27(4), 211-217.
Junger, W.G. (2011). Immune Cell Regulation by Autocrine Purinergic Signaling. Nature Reviews Immunology, 11, 201-212.
Séror C., Melki M.T., Subra F., Raza S.Q., Bras M., Saïdi H., Nardacci R., Voisin L., Paoletti A., et al. (2011). Extracellular ATP Acts on P2Y2 Purinergic Receptors to Facilitate HIV-1 Infection. J. Exp Med, 208(9), 1823-34.
Guerra A.N., Fisette P.L., Pfeiffer Z.A., Quinchia-Rios, B.H., Prabhu U., Aga M., Denlinger L.C., Guadarrama A.G., Abozeid S., Sommer J.A., Proctor R.A. & Bertics P.J. (2003). Purinergic Receptor Regulation Of LPS-Induced Signaling and Pathophysiology. J. Endotoxin Res., 9(4), 256-63.
Winder, W. W., Hardie, D. G. (1999). AMP-activated Protein Kinase, a Metabolic Master Switch: Possible Roles in Type 2 Diabetes. Am J. Physiol, 277(1 Pt 1), E1–10.
Stapleton, D., Mitchelhill, K.I., Gao G., Widmer J., Michell B.J., Teh T., House C.M., Fernandez C.S., Cox T., Witters L.A. & Kemp B.E. (1996). Mammalian AMP-activated Protein Kinase Subfamily. J. Biol Chem, 271(2), 611–4.
Petit P., Loubatières-Mariani M.M., Keppens, S. & Sheehan, M.J. (1996). Purinergic Receptors and Metabolic Function. Drug Development Research, 39(3-4), 413–425.
- There are currently no refbacks.
How to do online submission to another Journal?
If you have already registered in Journal A, then how can you submit another article to Journal B? It takes two steps to make it happen:
1. Register yourself in Journal B as an Author
Find the journal you want to submit to in CATEGORIES, click on “VIEW JOURNAL”, “Online Submissions”, “GO TO LOGIN” and “Edit My Profile”. Check “Author” on the “Edit Profile” page, then “Save”.
Go to “User Home”, and click on “Author” under the name of Journal B. You may start a New Submission by clicking on “CLICK HERE”.
We only use the following emails to deal with issues about paper acceptance, payment and submission of electronic versions of our journals to databases:
firstname.lastname@example.org; email@example.com; firstname.lastname@example.org
Copyright © Canadian Research & Development Centre of Sciences and Cultures (CRDCSC)
Address:730, 77e AV, Laval, Quebec, H7V 4A8, Canada
Telephone: 1-514-558 6138